SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors react to a massive twenty-year, multi-billion dollar data center lease with AI leader Anthropic, though shares face volatility amid broader market rotation and sector-wide profit-taking. Community discussion remains polarized between long-term bulls praising the strategic shift toward AI infrastructure and frustrated traders reacting to the sharp price swings that followed the announcement.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is attracting intense investor attention as its high-speed networking solutions become critical infrastructure for scaling AI data centers and supporting hyperscaler demand. Despite recent share price volatility following an earnings report, the community remains heavily focused on the company's long-term leadership in the AI buildout and the continued upward trajectory of institutional price targets.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is experiencing a significant surge in trading volume and investor interest following reports that China may ease restrictions on the import of advanced Nvidia AI chips, providing a potential tailwind for its cloud and AI operations. The community is actively debating whether this movement represents a structural turnaround for Chinese tech equities or a tactical rotation driven by the stock's significant discount to its US counterparts.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is currently drawing significant community attention as investors debate whether to buy the dip following a recent earnings release and monthly sales report, with many discussions centering on the long-term growth potential and persistent speculation regarding a possible stock split.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is currently trending as investors weigh strong insider accumulation and institutional confidence against the recent public offering. The community is focused on the company's robust pipeline, particularly the potential of its epilepsy and obesity programs, while remaining attentive to management's strategy for navigating regulatory challenges.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global Inc. is attracting significant investor attention as energy security concerns and global supply tightness remain at the forefront of community discussion. Traders are closely monitoring the stock's volume and recent price action, often linking its momentum to broader energy sector themes and the ongoing volatility in international LNG markets.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened retail interest as investors speculate on a potential short squeeze, citing high borrow fees and a tightly held share structure similar to past parabolic runs. The community is actively debating the stock's volatility potential while monitoring technical levels for a breakout.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors weigh strong long-term AI infrastructure demand against a sharp recent pullback that has triggered intense debate over technical support levels and valuation. The community remains divided between those panic-selling amid concerns of sector-wide rotation and those aggressively accumulating shares on the dip, viewing the recent volatility as a temporary shakeout of weak hands.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending due to significant momentum in the AI hardware and server infrastructure space, fueled by strong backlog growth and increasing analyst optimism. The community is actively discussing its relative strength against broader market volatility and its evolving role in enterprise AI ecosystems, often comparing its stability and long-term potential to other key industry hardware players.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is seeing heightened market attention following a strategic collaboration with Jazz Pharmaceuticals, which investors view as strong validation of the company's T-cell engager technology. Community discussion remains polarized, with bulls focused on the upcoming Q3 Phase 2 data readout for ABCL635 and a strengthened board of directors, while bears continue to scrutinize the company's historical price performance and ongoing cash burn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today

Equity

The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans. 


PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff?

Passage Bio said on Wednesday that it will merge with privately held Remix Therapeutics. 


Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside?

Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside...

This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

Wall Street analysts changed outlook for top names, including downgrading Mohawk Industries and Passage Bio. See analyst ratings for these stocks.read more...

Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock

Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the business's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

Insider Selling: Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock

Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the firm's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates

(RTTNews) - PASSAGE BIO, INC. (PASG) announced Loss for third quarter that decreased from the same period last year and beat the Street estimates...

Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet

The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

The mean of analysts' price targets for Passage Bio (PASG) points to a 1415.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Passage Bio Inc

Bearish Sentiment

Buying the dip

Waiting for more downside before stepping in

Already fully invested, just watching

Staying in cash - too much uncertainty

Stocks are pulling back hard as fresh war-resumption fears rattle markets - is this a buying opportunity or the start of more pain? Vote in this poll then check the results to see what other traders and investors are doing. Explain your reasoning in the comments.

The market is getting hit hard on fresh war-resumption fears - what&#39;s your move?

Stocktwits

The market is getting hit hard on fresh war-resumption fears - what's your move?

Current Price	$4.82
Prev Close	$5.00
Open	$4.92
Dividend Yield	0.00%
50-Day Moving Average	$5.24
Beta	1.83
Avg. Volume	144,004.19
PE Ratio	-0.42

52-Week High	$20.00
52-Week Low	$3.29
Market Capitalization	$16.06M
EPS (Annual)	-$14.35
Price to Book	1.36
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

PASGPassage Bio Inc

Latest PASG News